Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.78 -0.23 (-3.83%)
As of: Nov 12, 2026 · 10:18 AM EST

Orchestra BioMed Holdings (OBIO) Return on Sales [ROS] (2022 - 2026)

Updated

Orchestra BioMed Holdings (OBIO) reported Return on Sales [ROS] of -25404.55% for Q2 2026, down 23092.70 percentage points from -2311.84% a year earlier and down 5335.45 percentage points from the prior quarter.

Analysis

Orchestra BioMed Holdings (OBIO) Return on Sales [ROS] (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Orchestra BioMed Holdings' Return on Sales [ROS] came in at -181.36%, up 2239.40 percentage points year-over-year; for FY2025, it was -154.73%, up 2282.76 percentage points from FY2024.

  • Return on Sales [ROS] has a three-year change of +769.61 percentage points (FY2022 to FY2025).
  • By year, Return on Sales [ROS] came in at -2437.49% in FY2024 (-571.33 pp), -1866.16% in FY2023 (-941.82 pp) and -924.34% in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2022.
  • Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of -4385.96 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q4 2025 (a gain of 6613.55 percentage points); the low point was Q2 2026 (a drop of 23092.70 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -20069.09% (Q1 2026), 21.85% (Q4 2025) and -2359.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 10.44%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 19.44%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 18.08%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 17.44%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 6.36%
10 Orchestra BioMed Holdings 352.13 Mn -49.69 Mn 63,000.00 -25,600.00%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -25,600.00%
Jun 30, 2026 -25,404.55%
Mar 31, 2026 -20,069.09%
Dec 31, 2025 21.85%
Sep 30, 2025 -2,359.23%
Jun 30, 2025 -2,311.84%
Mar 31, 2025 -2,179.84%
Dec 31, 2024 -6,591.70%
Sep 30, 2024 -1,655.72%
Jun 30, 2024 -2,166.97%
Mar 31, 2024 -2,326.29%
Dec 31, 2023 -4,763.74%
Sep 30, 2023 -3,466.35%
Jun 30, 2023 -1,415.96%
Mar 31, 2023 -991.84%
Dec 31, 2022 -891.02%
Sep 30, 2022 -865.61%
Jun 30, 2022 -1,903.74%
Mar 31, 2022 -592.15%
API Access

Orchestra BioMed Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OBIO&period=max&api_key=YOUR_API_KEY